Cutera, Inc. Stock

Equities

CUTR

US2321091082

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX 03:51:26 2024-04-19 pm EDT 5-day change 1st Jan Change
1.905 USD -17.17% Intraday chart for Cutera, Inc. -11.76% -44.68%
Sales 2023 212M Sales 2024 * 163M Capitalization 45.91M
Net income 2023 -151M Net income 2024 * -131M EV / Sales 2023 0.33 x
Net cash position 2023 * - Net cash position 2024 * - EV / Sales 2024 * 0.28 x
P/E ratio 2023
-0.46 x
P/E ratio 2024 *
-0.42 x
Employees 540
Yield 2023 *
-
Yield 2024 *
-
Free-Float 95.14%
More Fundamentals * Assessed data
Dynamic Chart
1 day-3.36%
1 week+19.17%
Current month+56.46%
1 month+25.68%
3 months-23.97%
6 months-48.08%
Current year-34.75%
More quotes
1 week
1.84
Extreme 1.8407
2.53
1 month
1.28
Extreme 1.2801
2.68
Current year
1.28
Extreme 1.2801
4.97
1 year
1.28
Extreme 1.2801
23.66
3 years
1.28
Extreme 1.2801
74.38
5 years
1.28
Extreme 1.2801
74.38
10 years
1.28
Extreme 1.2801
74.38
More quotes
Managers TitleAgeSince
Chief Executive Officer 48 23-05-18
Director of Finance/CFO 58 21-06-30
Chief Tech/Sci/R&D Officer 61 19-09-30
Members of the board TitleAgeSince
Director/Board Member 68 21-05-16
Director/Board Member 66 -
Chief Executive Officer 48 23-05-18
More insiders
Date Price Change Volume
24-04-19 1.959 -14.81% 950 071
24-04-18 2.3 -3.36% 1,128,061
24-04-17 2.38 +18.41% 1,529,811
24-04-16 2.01 -9.05% 974,624
24-04-15 2.21 0.00% 2,358,528

Delayed Quote Nasdaq, April 18, 2024 at 04:00 pm EDT

More quotes
Cutera, Inc. develops, manufactures, distributes, and markets energy-based product platforms for medical practitioners, enabling them to offer treatments to their customers. The Company distributes third-party manufactured skincare products and secret systems and consumables. Its system platforms include AviClear, enlighten, excel, truSculpt, Secret PRO, Secret RF, and xeo. The Company’s Cutera Core segment consists of the Company’s systems, consumables, skincare, and service businesses. The Cutera Core segment develops, distributes and manufactures energy-based systems for medical practitioners in addition to distributing third-party manufactured skincare products in Japan. The Company’s AviClear segment consists of the AviClear business. The Company’s acne solution, AviClear, is a prescription-free, drug-free laser treatment for the treatment of mild to severe acne. Its products include CUTERA, ACUTIP 500, AVITM, AVI360, AVIANALYTICSTM, AVICARE COOLGLIDE, and more.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
2.3 USD
Average target price
6.333 USD
Spread / Average Target
+175.36%
Consensus